In domo » Hkeybio » Core Technology

HKYBIO BIOTECHNOLOGY

Have centum est animal exempla et autoimmune morbo secundum orci features et target machinationes actionis, et aestimandas variis formae innovative medicinae in his exempla; Et habet plus quam X genera NHP autoimmune morbus exempla; More autoimmune morbus exempla sunt developed;
Rich experientia in investigationis et progressionem novis medicamentis ad autoimmune morbo, bonum ad exploring differentiation commoda innovative pharmaca ad autoimmune morbo, ita ut accelerate processus of novum medicamento et progressionem;
Rich experientia in Ind declarationem domi et foris, nota cum communicationis Insidijs et artes cum FDA et NMPA in preclinical investigationis;
Explorationis et development of Molecular et cellular et cellular biomarkers, et potest develop specifica biomarkers pro diversis peltas novis medicinae et diversis autoimmune indicia;
Peritus in progressionem et deprehendatur in vitro immune munus methodologia, potest deprehendere ad munus mutationes diversis T cellula subtypes, B cellulis, NK cellulis, macrophages et alia cellulis.
HKEYBIO est contractus Research Organization (CRO) specialiter in preclinical investigationis in agro autoimmune morbo.

Quick Links

Service Catagory

Contact Us

  Phone
Negotia procurator-Julie Lu: + 86- 18662276408
Business inquisitionis-voluntatem Yang: + 86- 17519413072
Technical Consultation-Evan Liu: + 86- 17826859169
  info@hkeybio.com; tech@hkeybio.com
   Add: Building B, No.388 Xingping Street, ascendas Ihub Suzhou Industrial Park, Jiangsu, Sina
Relinquere nuntium
Contact Us
Subscribere sursum pro nostra Newsletter ad recipere tardus nuntium.
Copyright © 2024 hkeybio. Omnes ligula. Squama Sitemap | Privacy Policy